Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-25 @ 7:43 PM
NCT ID:
NCT00532935
Pre Assignment Details:
Patients 18-78 years old with Type 2 Diabetes Mellitus (T2DM), drug-naïve (off antihyperglycemic agent
\[AHA\] for at least 3 months prior to screening, and a maximum 4 weeks cumulative AHA therapy over the
previous 3 years), hemoglobin A1C 7.5 to 12% were eligible. Eligible patients underwent a 2-week placebo
run-in period prior to randomization.
Recruitment Details:
First Patient In: 19-Mar-2008
Last Patient Last Visit: 23-Oct-2009
Seventy-four medical clinics worldwide (19 sites in the United States, 31 in Eastern Europe, and 24 in the rest of the world).
Study:
NCT00532935
Study Brief:
Results Section:
NCT00532935